Treatment of inflammatory diseases with inhibitors of C5a activity
US11273225B2 · kind B2 · utility
4Cited by
4References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 13, 2018 |
| Grant date | Mar 15, 2022 |
| Priority date | — |
| Expiry date | Sep 2, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to inhibitors of C5a activity and their use in the treatment of cutaneous, neutrophilic, inflammatory diseases in a subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.